Friday, September 20, 2024

Jigawa presents free healthcare to hypertension, diabetes, sickle cell Sufferers

The Jigawa State Authorities mentioned hypertension, diabetes and sickle cell sufferers will obtain free healthcare companies within the state.

The Commissioner for Info, Youth, Sport and Tradition, Mr Sagir Musa, made this recognized in a press release in Dutse, the state capital, on Friday.

Musa mentioned the State Govt Council, throughout its assembly on Thursday, permitted that the state programme for Free Maternal Neonatal and Little one Healthcare must also cowl folks with hypertension, diabetes and sickle cell without cost therapy in all government-owned hospitals throughout the 27 Native authorities areas.

He defined that the council additionally permitted the disbursement of N179.2 million as Direct Facility Financing to the accredited Main Healthcare Facilities.

Council, he mentioned, additionally permitted a further 17 PHCs throughout the 281 political wards of the state for the primary and second quarters of 2024 by the Nationwide Main Well being Care Growth Company.

The commissioner added that N69.1 million was additionally permitted for the fee of month-to-month stipend for 79 Midwives and Group Influencers, Promoters and Providers (CHIPS Brokers).

In keeping with him, a piece plan for the implementation of Immunisation Plus and Malaria Progress by Accelerating Protection and Remodeling Providers Undertaking introduced by the Ministry of Well being, was additionally permitted.

“The IMPACT Undertaking is supported by World Financial institution with a complete quantity of N1.2 billion solely within the Work plan for the yr 2024 for Jigawa for the revitalisation of 161 Main Healthcare Centres within the state,” Musa mentioned.

NAN.

All rights reserved. This materials, and different digital content material on this web site, is probably not reproduced, revealed, broadcast, rewritten or redistributed in complete or partially with out prior specific written permission from PUNCH.

Contact: [email protected]

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles